The MHRA has approved tisotumab vedotin for adults with recurrent or metastatic cervical cancer, offering a new option after earlier treatment failure.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/uk-approves-targeted-therapy-cervical-cancer-2025a1000xut?src=rss
Author :
Publish date : 2025-12-03 12:49:00
Copyright for syndicated content belongs to the linked Source.